Slingshot Biosciences

📍 Emeryville, United States🗓 Founded 2012👥 61 employees💰 Last funded Jul 2021
Biotechnology Research🌐 slingshotbio.com
Website LinkedIn
Slingshot Biosciences is working on an overlooked but ubiquitous problem in healthcare that has a tremendous impact on a variety of patient outcomes: the lack of consistent reference material for cell-based assays. The company’s cell mimics represent a new way to use control material in the workflow, whether for instrument manufacturing, assay setup, and validation or as a manufacturing QC control. Synthetic cell mimics provide a new opportunity for precise, biologically-relevant, and cost-effective controls to aid many healthcare and research efforts globally. Learn more at slingshotbio.com
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Slingshot Biosciences?
Slingshot Biosciences has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Slingshot Biosciences last raise funding?
The most recent investment in Slingshot Biosciences recorded on gritt.io was in July 2021.
When was Slingshot Biosciences founded?
Slingshot Biosciences was founded in 2012.
What industry is Slingshot Biosciences in?
Slingshot Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Slingshot Biosciences based?
Slingshot Biosciences is headquartered in Emeryville, United States.